目的:比较特比萘芬与伊曲康唑治疗甲癣疗效的差异.方法:检索Medline等数据库,查找所有比较特比萘芬与伊曲康唑治疗18~60 a无系统疾病所患甲癣的双盲随机对照试验的文献,记录这2种药物治疗甲癣的真菌学治愈率并对其进行汇总分析,得出合并后真菌学治愈率的优势比(OR)及其95%的可信区间(CI).结果:经筛选,共得到6篇符合标准的双盲随机对照试验;特比萘芬250 mg·d-1连续疗法组的真菌学治愈率高于伊曲康唑400 mg·d-1冲击疗法[OR=5.01,95%CI(3.42~7.33)]和伊曲康唑200 mg·d-1连续疗法[OR=2.58,95%CI(1.91~3.49)].结论:特比萘芬治疗甲癣的疗效优于伊曲康唑.中文核心期刊要目总览(PKU)中国科学引文数据库(CSCD)011809-8122
Background: Fusarium onychomycoses are weakly responsive or unresponsive to standard onychomycosis t...
目的:研究伊曲康唑间歇冲击疗法治疗趾甲真菌病(甲母质未受累)的疗效和在血清及甲中药物水平的变化.方法:41例趾甲真菌病患者应用伊曲康唑连续3个冲击治疗,第52周进行最终疗效评价;采用高压液相色谱仪(H...
The purpose of this literature research project is to investigate the efficacy and safety of terbina...
Objectives To compare the efficacy, safety and tolerability of oral terbinafine with itraconazole in...
Background: Toenail onychomycosis is a challenge for clinicians to treat. While both Itraconazole a...
目的 本试验探讨特比萘芬和伊曲康唑单独及联合应用对54株暗色孢科真菌的体外相互作用.方法 应用美国国家临床和实验室标准研究所(CLSI)的M38-A方案.菌悬液终浓度为(0.4~5)&#215...
目的 初步探讨伊曲康唑和特比萘芬联合治疗孢子丝菌病的疗效,评价两药体外联合对申克孢子丝菌菌丝相和酵母相的抗菌活性.方法 口服伊曲康唑200mg/d和特比萘芬250mg/d治疗孢子丝菌病;体外联合药敏试...
Background: Superficial mycoses are common worldwide. Dermatophytic infections can greatly affect qu...
BACKGROUND: Onychomycosis is a recalcitrant disease of the nails caused by dermatophytes, yeasts, a...
In this randomized double‐blind trial, two new antifungal compounds were compared in patients with i...
目的 观察皮肤癣菌在伊曲康唑作用下的形态学变化.方法 应用美国CLSI制订的标准M38-A方案进行伊曲康唑对皮肤癣菌的体外药敏试验,测定最小抑菌浓度(MIC),将伊曲康唑作用前后的皮肤癣菌分别制成标本...
目的 评价特比萘芬、伊曲康唑和氟康唑体外对28株甲真菌病白念珠菌的相互作用方式.方法 参照美国国家实验室标准委员会(NCCLS) M27方案(1997)推荐的棋盘微量稀释法,检测了28株分离自甲真菌病...
PURPOSE: We estimated the absolute risks of treatment termination and incidence of adverse liver out...
Background: In a hot and humid country like India, the prevalence of superficial mycotic infections ...
Onychomycosis is a common fungal infection of nail plate caused by dermatophytes, non dermatophyte m...
Background: Fusarium onychomycoses are weakly responsive or unresponsive to standard onychomycosis t...
目的:研究伊曲康唑间歇冲击疗法治疗趾甲真菌病(甲母质未受累)的疗效和在血清及甲中药物水平的变化.方法:41例趾甲真菌病患者应用伊曲康唑连续3个冲击治疗,第52周进行最终疗效评价;采用高压液相色谱仪(H...
The purpose of this literature research project is to investigate the efficacy and safety of terbina...
Objectives To compare the efficacy, safety and tolerability of oral terbinafine with itraconazole in...
Background: Toenail onychomycosis is a challenge for clinicians to treat. While both Itraconazole a...
目的 本试验探讨特比萘芬和伊曲康唑单独及联合应用对54株暗色孢科真菌的体外相互作用.方法 应用美国国家临床和实验室标准研究所(CLSI)的M38-A方案.菌悬液终浓度为(0.4~5)&#215...
目的 初步探讨伊曲康唑和特比萘芬联合治疗孢子丝菌病的疗效,评价两药体外联合对申克孢子丝菌菌丝相和酵母相的抗菌活性.方法 口服伊曲康唑200mg/d和特比萘芬250mg/d治疗孢子丝菌病;体外联合药敏试...
Background: Superficial mycoses are common worldwide. Dermatophytic infections can greatly affect qu...
BACKGROUND: Onychomycosis is a recalcitrant disease of the nails caused by dermatophytes, yeasts, a...
In this randomized double‐blind trial, two new antifungal compounds were compared in patients with i...
目的 观察皮肤癣菌在伊曲康唑作用下的形态学变化.方法 应用美国CLSI制订的标准M38-A方案进行伊曲康唑对皮肤癣菌的体外药敏试验,测定最小抑菌浓度(MIC),将伊曲康唑作用前后的皮肤癣菌分别制成标本...
目的 评价特比萘芬、伊曲康唑和氟康唑体外对28株甲真菌病白念珠菌的相互作用方式.方法 参照美国国家实验室标准委员会(NCCLS) M27方案(1997)推荐的棋盘微量稀释法,检测了28株分离自甲真菌病...
PURPOSE: We estimated the absolute risks of treatment termination and incidence of adverse liver out...
Background: In a hot and humid country like India, the prevalence of superficial mycotic infections ...
Onychomycosis is a common fungal infection of nail plate caused by dermatophytes, non dermatophyte m...
Background: Fusarium onychomycoses are weakly responsive or unresponsive to standard onychomycosis t...
目的:研究伊曲康唑间歇冲击疗法治疗趾甲真菌病(甲母质未受累)的疗效和在血清及甲中药物水平的变化.方法:41例趾甲真菌病患者应用伊曲康唑连续3个冲击治疗,第52周进行最终疗效评价;采用高压液相色谱仪(H...
The purpose of this literature research project is to investigate the efficacy and safety of terbina...